MAINTENANCE THERAPY OF CHRONIC PSYCHOTICS WITH PERPHENAZINE
Abstract
Perphenazine was used to treat 300 psychotic patients. The dosage usually ranged between 16 and 4 mg. three times daily, for 1 to 9 months. Remission or significant improvement occurred among 80% of first-admission patients and among 70% of those who had had one or several previous admissions. Mild pseudoparkinsonism during high dosage was the only significant side effect.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
